Title : To ablate or not to ablate the endometrium in dysfunctional uterine bleeding: That is the question!
Abstract:
Endometrial Ablation (EA) has become one of the most commonly performed gynaecologic procedures in the developed and developing countries. Global Endometrial Ablation (GEA) devices have supplanted resectoscopic ablation, primarily because they have brought with them technical simplicity and unprecedented safety. These devices are typically used to treat Dysfunctional Uterine Bleeding (DUB) in premenopausal women. However, there is a widespread concern about the effect of ablation on the incidence and development of endometrial cancer in such population, and whether such ablative techniques introduce a masking effect resulting in delayed diagnosis of endometrial cancer or does it provide a protective effect against it?
Audience Take Away:
- Endometrial sampling must be done in a different setting before the patient is booked for endometrial ablation. Endometrial ablation should not be done with any type of endometrial hyperplasia, even the simple one
- Endometrial ablation might introduce a protective effect against endometrial carcinoma.
- There should not be a widespread concern about the effect of ablation on the incidence and development of endometrial cancer
- Endometrial ablative techniques do not introduce a masking effect resulting in delayed diagnosis of endometrial cancer
